Oncofertility: An emerging discipline in obstetrics and gynecology

Obstetrical and Gynecological Survey

Volumn 68, Issue 8, 2013, Pages 582-593

  Lange, Sara ^a   Tait, David ^a   Matthews, Michelle ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTIMETABOLITE; ANTINEOPLASTIC ANTIBIOTIC; BLEOMYCIN; CARBOPLATIN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; GESTAGEN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADOTROPIN; IFOSFAMIDE; LETROZOLE; METHOTREXATE; PACLITAXEL; PREDNISOLONE; PROCARBAZINE; TAMOXIFEN; VINCRISTINE;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CRYOPRESERVATION; ENDOMETRIUM CANCER; FEMALE INFERTILITY; FERTILITY; GYNECOLOGIC CANCER; GYNECOLOGIST; HEMATOLOGIC MALIGNANCY; HUMAN; IMMATURITY; NEOPLASM; ONCOFERTILITY; OOCYTE; OVARY CANCER; OVARY FOLLICLE DEVELOPMENT; POPULATION RESEARCH; REPRODUCTIVE PROCEDURE; TESTIS FUNCTION; TISSUE PRESERVATION; UTERINE CERVIX CANCER; UTERUS CANCER;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CRYOPRESERVATION; EMBRYO, MAMMALIAN; FEMALE; FERTILITY PRESERVATION; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; LEUKEMIA; LYMPHOMA; MALE; MEDICAL ONCOLOGY; OBSTETRICS; OOCYTES; OVARY; PHYSICIAN'S ROLE; RADIOTHERAPY; SPERMATOZOA;

EID: 84883342997     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e31829d460d     Document Type: Article

References (55)

1. Duncan FE, Jozefik JK, Kim AM, et al. The gynecologist has a unique role in providing oncofertility care to young cancer patients. US Obstet Gynecol. 2011;6:24-34.
2. National Cancer Institute. A snapshot of adolescent and young adult cancers. Last updated Oct 2012. Calculated by SEER Program using SEER 18, 2005-2009. Available at: http://www. cancer.gov/researchandfunding/snapshots/ adolescent-youngadult. Accessed May 8, 2013.
3. Bodurka DC. Women's cancer survivorship: time to gear up! Gynecol Oncol. 2012;124:377-378.
4. Noyes N, Knopman JM, Long K, et al. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol. 2011;120:326-333.
5. Noyes N, Reh A, Mullin C, et al. Quality-of-life (QOL) assessment at time of fertility preservation (FP) counseling in female fertility patients: results of a university-based registry at two years. J Clin Oncol. 2010;28(supp15): e1964.
6. Anderson RA, Cameron DA. Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab. 2011;96:1336-1343.
7. Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve. Fertil Steril. 2012;98:1407-1415.
8. Wallace WHB. Oncofertility and preservation of reproductive capacity in children and young adults. Cancer. 2011; 117(suppl 10):2301-2310.
9. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117-121.
10. Green DM, Sklar CA. Boice JD, et al. Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the childhood cancer survivor study. J Clin Oncol. 2009;27:2374-2381.
11. Whitehead E, Shalet SM, Blackledge G, et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer. 1983;52:988-993.
12. Wallace WHB, Shalet SM, Crowne EC, et al. Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol. 1989;17: 409-413.
13. van der Kaaij MAE, van Echten-Arends J, Simons AHM, et al. Fertility preservation after chemotherapy for Hodgkin lymphoma. Hematol Oncol. 2010;28:168-179.
14. Tarumi W, Suzuki N, Takahashi N, et al. Ovarian toxicity of paclitaxel and effect on fertility in the rat. J Obstet Gynaecol Res. 2009;35:414-420.
15. Adewole IF, Rustin GJS, Newlands ES, et al. Fertility in patients with gestational trophoblastic tumors treated with etoposide. Eur J Cancer Clin Oncol. 1986;22:1479-1482.
16. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24:2917-2931.
17. Ajala T, Rafi J, Larsen-Disney P, et al. Fertility preservation for cancer patents: a review. Obstet Gynecol Int. 2010;ID160386:1-9.
18. Goodwin PJ, Ennis M, Prichard KI, et al. Risk of menopause during the first year after breast cancer. J Clin Oncol. 1999; 17:2365-2370.
19. Parulekar WR, Day AG, Ottaway JA, et al. Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a national cancer institute of Canada clinical trials group studyVNCIC CTG MA.5. J Clin Oncol. 2005;23:6002-6008.
20. Tancini G, Valagussa P, Bajetta E, et al. Preliminary 3-year results of 12 vs 6 cycles of surgical adjuvant CMF in premenopausal breast cancer. Cancer Clin Trials. 1979;2:285-292.
21. Bianco AR, Del Mastro L, Gallo C, et al. Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer. Br J Cancer. 1991;63:799-803.
22. Burstein HJ, Winer EP. Primary care for survivors of breast cancer. N Engl J Med. 2000;343:1086-1094.
23. Berliere M, Dalenc F, Malingret N, et al. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer. 2008;8:1-9.
24. Shalet SM, Tsatsoulis A, Whitehead E, et al. Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol. 1989;120:161-165.
25. Viviani S, Santoro A, Ragni G, et al. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol. 1985;21: 601-605.
26. Anselmo AP, Cartoni C, Bellantuono P, et al. Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/MOPP. Haematologica. 1990;75:155-158.
27. Jemel A, Murray T, Ward E, et al. Cancer statistics 2005. CA Cancer J Clin. 2005;55:10-30.
28. Cancer facts and figures 2011. American Cancer Society, Atlanta, Georgia. Available at: http://www.cancer.org/Research/CancerFactsFigures/ CancerFactsFigures/cancer-facts-figures-2011.
29. ISFP Practice Committee. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet. 2012;29:465-468.
30. Sonmezer M, Turkcuoglu I, Coskun U, et al. Random-start ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil Steril. 2011;95:2125.e9-2125.e11.
31. Noyes N, Labella P, Grifo J, et al. Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors. J Assist Reprod Genet. 2010;27:495-499.
32. Oktay K, Buyuk E, Davis O, et al. Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod. 2003;18:90-95.
33. Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol. 2005;23: 3858-3860.
34. Nagy ZP, Chang CC, Kort HI, et al. Comparison of vitrified/warmed donated oocyte treatment outcomes in GnRHantagonist cycles where hCG or Luproni was used to trigger ovulation. Fertil Steril. 2010;94:s160-s161.
35. American Cancer Society. Cancer Facts and Figures; 2010. Available at: http://www.cancer.org/acs/groups/content/@nho/documents/acspc-024113.pdf. Accessed February 3, 2013.
36. Cancer statistics, 2013. Cancer J Clin. 2013;63:12-13.
37. Gunderson CC, Fader AN, Carson KA, et al. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review. Gynecol Oncol. 2012;125:477-482.
38. Walsh C, Holschneider C, Hoang Y, et al. Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol. 2005;106:693-699.
39. Zivanovic O, Carter J, Kauff ND, et al. A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer. Gynecol Oncol. 2009;115:504-509.
40. Richter CE, Qian B, Martel M, et al. Ovarian preservation and staging in reproductive-age endometrial cancer patients. Gynecol Oncol. 2009;114:99-104.
41. Gien LT, Covens A. Fertility-sparing options for early stage cervical cancer. Gynecol Oncol. 2010;117:350-357.
42. Milliken DA, Shepherd JH. Fertility preserving surgery for carcinoma of the cervix. Curr Opin Oncol. 2008;20:575-580.
43. Persson J, Imboden S, Reynisson P, et al. Reproducibility and accuracy of robot-assisted laparoscopic fertility sparing radical trachelectomy. Gynecol Oncol. 2012;127:484-488.
44. Siegel R, Ward E, Brawley O, et al. Cancer statistics 2011. CA Cancer J Clin. 2011;61:212-236.
45. Gershenson DM. Treatment of ovarian cancer in young women. Clin Obstet Gynecol. 2012;55:65-74.
46. Fruscio R, Corso S, Ceppi L, et al. Conservative management of early-stage epithelial ovarian cancer: results of a large retrospective series. Ann Oncol. 2012;00:1-7.
47. ASRM Practice Committee Report. Mature oocyte cryopreservation: a guideline. Fertil Steril. 2013;99:37-43.
48. National Data Summary. Available at: http://www.sart.org. Accessed May 7, 2013.
49. Donnez J, Squifflet J, Jadoul P, et al. Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation. Fertil Steril. 2011;95:1787 e1-e4.
50. Smitz J, Dolmans MM, Donnez J, et al. Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update. 2010;16:395-414.
51. Zeilmaker G, Alberda A, van Gent I, et al. Two pregnancies following transfer of intact frozen-thawed embryos. Fertil Steril. 1984;42:293-296.
52. ASRM Ethics Committee Report. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622-1628.
53. Dolmans MM, Marinescu C, Saussoy P, et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116: 2908-2914.
54. Schlatt S, Ehmcke J, Jahnukainen K. Testicular stem cells for fertility preservation: preclinical studies on male germ cell transplantation and testicular grafting. Pediatr Blood Cancer. 2009;53:274-280.
55. Campo-Engelstein L. Consistency in insurance coverage for iatrogenic conditions resulting from cancer treatment including fertility preservation. J Clin Oncol. 2010;28:1284-1286.